Skip to main content
Header logo
  • About Moberg Open link menu
    About Moberg
    • CEO Comments
    • Business Model
    • Board and Leadership
  • MOB-015
  • Sustainability
  • Investors Open link menu
    Investors
    • Results and Presentations
    • The share Open link menu
      The share
      • Major shareholders
      • Insider Trading
      • Financial Data
    • Analysts
    • Calendar
    • Corporate governance Open link menu
      Corporate governance
      • Board of directors
      • Management
      • General shareholders meetings
      • Nomination committee
      • Auditors
      • Remuneration
      • Share-based incentive program
      • Articles of Association
    • Press releases
    • Prospectus
  • Media Open link menu
    Media
    • Image Archive
    • Press Releases
  • Contact
    • EN Current language English, click to switch language
    • SV Switch to Swedish
  • Please fill out this field
Close
Please fill out this field

Redeye Life Science Day

  • Read more about Redeye Life Science Day

EuroPLX, Berlin

  • Read more about EuroPLX, Berlin

BioEurope 2025, Vienna

  • Read more about BioEurope 2025, Vienna

PharmaSynergy OTC, Rome

  • Read more about PharmaSynergy OTC, Rome

EADV, Paris

  • Read more about EADV, Paris

Year-end report 2024

  • Read more about Year-end report 2024

EuroPLX, Vienna

  • Read more about EuroPLX, Vienna

BioEurope Spring, Milan

  • Read more about BioEurope Spring, Milan

Redeye Consumer Health

  • Read more about Redeye Consumer Health

Interim report for January - September 2025

  • Read more about Interim report for January - September 2025

Pagination

  • Page 1
  • Next page ››
Subscribe to 2025

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address: 
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address: 
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Sign up

Home
Moberg Pharma´s Interim report January - September 2024

Footer

  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Cookies
  • Copyright
  • Cookie settings
  • © Moberg Pharma AB (publ) 2026